News

Sort news by
12/11/2014 - 9:31am

Isis Pharmaceuticals, Inc. has initiated a Phase I/II trial for ISIS-DMPKrx in patients affected by myotonic dystrophy type 1 (DM1).

10/16/2014 - 3:36pm

Dr. John Vissing and his colleagues at the University of Copenhagen recently tracked a group of 68 adults with myotonic dystrophy type 1 (DM1), measuring their endocrine function change over 8 years.

09/25/2014 - 9:48am

Researchers from Dr. Matthew Disney's lab at the Scripps Research Institute of Florida recently published an article describing a new chemical they designed to inhibit the unhealthy repeat-containing RNA molecule seen in DM2.

08/20/2014 - 3:12pm

Join the Myotonic Dystrophy Family Registry; you could win an iPad! 

08/20/2014 - 11:05am

New research on the impact of the mother's age on congenitally affected offspring.

Pages